The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Travel
  • Real Estate
  • Technology
  • Education
  • Marketing

Olympus Acquires Veran Medical Technologies, Inc.
The PennZone/10102444

Trending...
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
  • Award-Winning REALTOR® Paige Coker Joins Corcoran DeRonja Real Estate
CENTER VALLEY, Pa. and TOKYO, Dec. 30, 2020 /PRNewswire/ -- Olympus Corporation today announced that it has finalized the acquisition of Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, following the definitive agreement the two companies signed December 4, 2020. With this acquisition by Olympus subsidiary Olympus Corporation of the Americas (OCA), Olympus gains VMT's global sales network, marketing, manufacturing, R&D, and other functions to expand the Olympus respiratory product portfolio.

Lung cancer is the leading cause of cancer-related deaths globally.1 With increased awareness and more lung cancer screenings using low-dose computed tomography (CT), the need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase. VMT's SPiN Thoracic Navigation System® and related devices are specifically designed to help physicians navigate to, localize, and sample peripheral pulmonary lesions. Together with the existing Olympus respiratory portfolio that includes radial endobronchial ultrasound (EBUS) and thin bronchoscopes, VMT's navigational system and related devices provide a powerful combination of imaging, access and precision for pulmonologists seeking to diagnose and determine the stage of a patient's lung cancer.

More on The PennZone
  • J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
  • Tyler G. Hicks' Encyclopedia of Wealth Building Secrets Released in a Powerful New Edition
  • Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
  • New Book Gives Technology Leaders the Blueprint to Drive Real, Lasting Impact

"We are very excited about the synergies this acquisition creates. With the deal now closed, as one company we are able to combine Olympus' expertise and clinical history in minimally invasive technology with the innovation in navigation systems of Veran Medical Technology to improve workflow and patient care in lung cancer," said Lynn Ray, Vice President and General Manager of the Global Respiratory Business Unit for Olympus Corporation. "Olympus is committed to providing the medical community with the best tools possible to use in their fight against cancer. With the advent of EBUS-guided transbronchial needle aspiration (EBUS-TBNA) in 2004, Olympus brought patients the benefit of more accurate diagnosis and staging, to improve patient outcomes and care. We are thrilled to be at the forefront of development in this rapidly evolving area of respiratory care."

The acquisition will provide immediate incremental revenue and an experienced sales team within the U.S. market. VMT's advanced and proven navigation technology, together with Olympus' respiratory portfolio, strengthens and enhances Olympus' global position as a medical technology innovator.

As part of its current Corporate Strategy, Olympus vowed to "focus and scale" its Therapeutic solutions Division (TSD). To accelerate the process and provide greater agility, Olympus made OCA the TSD headquarters, recognizing the significant growth opportunities in North America. Olympus also identified three core medical fields to prioritize and has since focused on gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.

More on The PennZone
  • IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
  • AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
  • Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)
  • Mom Creators Coalition Launches with WaterWipes® as Official Founding Sponsor
  • PandaGuarantee Launches Rent Guarantor Service in New York City

For additional information, please refer to our corporate disclosure, "Notice regarding acquisition of Veran Medical Technologies, Inc. in the United States."

(available at: https://www.olympus-global.com/news/ir/2020/)

1 WHO data:  https://www.who.int/news-room/fact-sheets/detail/cancer

About Olympus' Therapeutic Solutions Division
In its Therapeutic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with its early contributions to the development of the polypectomy snare, Olympus' Therapeutic Solutions portfolio has grown to include an array of surgical energy devices and a wide range of instruments to help prevent, detect, and treat disease. For more information, visit www.olympus-global.com.

SOURCE Olympus

Related Links

http://www.olympus.com/
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • GDE Tree Services Expands Operations into Sydney, NSW
  • Tuckwell Machinery Expands CNC Range to Support Australian Cabinet Makers
  • The Inner Power of Emotional Self-Leadership
  • Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
  • Best Companies Group Opens Free Registration for Best Places to Work in Insurance Program
  • Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
  • Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
  • Mobile Copywriter Celebrates 13 Years of Content Creation and SEO Services
  • Award-Winning REALTOR® Paige Coker Joins Corcoran DeRonja Real Estate
  • Over 98% of crypto owners globally don't declare taxes, new report find
  • Happreneurs™ Business Community Launches Pittsburgh, PA Chapter with Powerful Network of Founding Leaders
  • TicTac Group acquires French EdTech company Distrisoft
  • Rhys-Davies, Wright, Norris, Jacinto Highlight Latest Wave of FAN EXPO Philadelphia Celebrity Guests
  • Mark Dobosz Makes Donorassess.org Free To Every Nonprofit On The Planet
  • Genpak Announces Closure of Utah Manufacturing Facility
  • Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
  • The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge

Popular on PennZone

  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • Conexwest: Shipping Containers Are Powering the Next Generation of Bitcoin Mining Infrastructure
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • Hope Survives Launches The Hope Collective, A Curated Publication Centering Lived Experience After Brain Injury
  • Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
  • Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
  • Jack and Sage Acquires Sustainable Apparel Brand Kastlfel, Expanding Premium Logo Wear Across National Parks and Ski Resorts

Similar on PennZone

  • L2 Aviation Earns FAA STC for Thales AVIATOR 200S for Boeing 777
  • HousingWire launches Mortgage Rankings, bringing a data-driven benchmark to originator performance
  • J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
  • IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
  • AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
  • Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)
  • Mom Creators Coalition Launches with WaterWipes® as Official Founding Sponsor
  • Daniel Kaufman Expands Kaufman & Company Real Estate Platform With New Acquisitions, AI-Driven Industrial Development and Nationwide Growth Initiative
  • NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
  • DC Accounting Firm Offers Free Business CRM to Small Business Clients Alongside Weekly Bookkeeping Model
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us